Literature DB >> 22340495

BRCA2 fine-tunes the spindle assembly checkpoint through reinforcement of BubR1 acetylation.

Eunhee Choi1, Pil-Gu Park, Hae-Ock Lee, Yoo-Kyung Lee, Gyeong Hoon Kang, Jong Won Lee, Wonshik Han, Ho Chang Lee, Dong-Young Noh, Sergey Lekomtsev, Hyunsook Lee.   

Abstract

Germline mutations that inactivate BRCA2 promote early-onset cancer with chromosome instability. Here, we report that BRCA2 regulates the spindle assembly checkpoint (SAC). Previously, we reported that BubR1 acetylation is essential for SAC activity. In this study we show that BRCA2 recruits the PCAF acetyltransferase and aids in BubR1 acetylation during mitosis. In the absence of BRCA2, BubR1 acetylation is abolished, and the level of BubR1 decreases during mitosis. Similarly, Brca2-deficient mouse embryonic fibroblasts exhibited weak SAC activity. Transgenic mice that were engineered to have interruptions in the BRCA2-BubR1 association exhibited marked decrease of BubR1 acetylation, weakened SAC activity, and aneuploidy. These transgenic mice developed spontaneous tumors at 40% penetrance. Moreover, immunohistochemical analyses of human breast cancer specimens suggested that BRCA2 mutation and BubR1 status is closely linked. Our results provide an explanation for how mutation of BRCA2 can lead to chromosome instability without apparent mutations in SAC components.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22340495     DOI: 10.1016/j.devcel.2012.01.009

Source DB:  PubMed          Journal:  Dev Cell        ISSN: 1534-5807            Impact factor:   12.270


  40 in total

Review 1.  Regulatory mechanisms of kinetochore-microtubule interaction in mitosis.

Authors:  Kozo Tanaka
Journal:  Cell Mol Life Sci       Date:  2012-07-04       Impact factor: 9.261

Review 2.  Homologous recombination and human health: the roles of BRCA1, BRCA2, and associated proteins.

Authors:  Rohit Prakash; Yu Zhang; Weiran Feng; Maria Jasin
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-04-01       Impact factor: 10.005

3.  Chromatin PTEN is involved in DNA damage response partly through regulating Rad52 sumoylation.

Authors:  Byeong Hyeok Choi; Yan Chen; Wei Dai
Journal:  Cell Cycle       Date:  2013-09-18       Impact factor: 4.534

Review 4.  Senescence and apoptosis: dueling or complementary cell fates?

Authors:  Bennett G Childs; Darren J Baker; James L Kirkland; Judith Campisi; Jan M van Deursen
Journal:  EMBO Rep       Date:  2014-10-13       Impact factor: 8.807

5.  Chromatin Remodeling in Response to BRCA2-Crisis.

Authors:  Joshua J Gruber; Justin Chen; Benjamin Geller; Natalie Jäger; Andrew M Lipchik; Guangwen Wang; Allison W Kurian; James M Ford; Michael P Snyder
Journal:  Cell Rep       Date:  2019-08-20       Impact factor: 9.423

6.  A functional genomics screen identifies PCAF and ADA3 as regulators of human granzyme B-mediated apoptosis and Bid cleavage.

Authors:  D Brasacchio; T Noori; C House; A J Brennan; K J Simpson; O Susanto; P I Bird; R W Johnstone; J A Trapani
Journal:  Cell Death Differ       Date:  2014-01-24       Impact factor: 15.828

Review 7.  Fanconi anaemia and cancer: an intricate relationship.

Authors:  Grzegorz Nalepa; D Wade Clapp
Journal:  Nat Rev Cancer       Date:  2018-01-29       Impact factor: 60.716

8.  FANCA safeguards interphase and mitosis during hematopoiesis in vivo.

Authors:  Zahi Abdul-Sater; Donna Cerabona; Elizabeth Sierra Potchanant; Zejin Sun; Rikki Enzor; Ying He; Kent Robertson; W Scott Goebel; Grzegorz Nalepa
Journal:  Exp Hematol       Date:  2015-09-11       Impact factor: 3.084

Review 9.  Molding BRCA2 function through its interacting partners.

Authors:  Juan S Martinez; Céline Baldeyron; Aura Carreira
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

10.  Homology-Directed Repair and the Role of BRCA1, BRCA2, and Related Proteins in Genome Integrity and Cancer.

Authors:  Chun-Chin Chen; Weiran Feng; Pei Xin Lim; Elizabeth M Kass; Maria Jasin
Journal:  Annu Rev Cancer Biol       Date:  2017-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.